Translation and Validation of the French mPCOSQ (mPCOSQ-F).
Recruiting · NCT07016035 · Observational (researchers observe without assigning treatment) · Lead sponsor: CHU de Reims
View the official record on ClinicalTrials.gov →Interventions studied
mPCOSQ-F and SF-36
What this trial is about
This study is a prospective, observational, bicentric study, evaluating the validity and reliability of a French version of the mPCOSQ questionnaire (mPCOSQ-F), used to assess health-related quality of life (HRQOL) in women with polycystic ovary syndrome. The first stage of the study consisted in translating the questionnaire from English to French. Patients agreeing to take part in the study will complete the mPCOSQ-F and the SF-36 (generic HRQOL questionnaire). After 1 to 2 weeks, patients will receive the mPCOSQ-F and complete it again.
Who can take part
Age range
18 Years to 45 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Women aged 18 to 45
- Fluent in french
- Having a diagnosis of PCOS according to the international recommendations published in 2023
- Willing to participate in the study
- Affiliated to the french social security system
Exclusion criteria
- Diagnosis of adrenal hyperplasia, androgen-producing tumor, Cushing's syndrome, or thyroid disorder
- Pregnancy or breast-feeding
- Under legal protection
Where it is running
1 location listed.
- Damien JOLLY - Reims, France